Interestingly, in a review by Chua et al. (2014), it was suggested that TSPO ligands may provide effective tools for treatment of AD through activation of neuroprotective pathways of increased expression of astrocytes and microglial cells, since these mechanisms may have a protective phagocytic role in early AD (Morgan et al., 2005). The gene discussed is TSPO; the disease is Alzheimer disease.